{
  "symbol": "LRCX",
  "company": "Lam Research Corporation",
  "generated_at": "2026-06-24T07:36:49.777Z",
  "event_count": 11,
  "events": [
    {
      "type": "scout_dossier",
      "ts": "2026-06-24T06:04:36.453Z",
      "summary": "The Form 4 cluster trigger was misleading — both recent filings (June 11 and June 12) represent open-market SALES by Director Eric Brandt under a pre-established Rule 10b5-1 plan adopted in February 2026, totaling ~107,500 shares sold at $337-$373. This is not insider buying; it is profit-taking during a +156% YTD run-up. No genuine open-market insider purchases were identified across the full 90-day window. The stock is trading at forward P/E of 46.4 against a sector median that does not justify this premium for an equipment name with ~34% China revenue concentration and significant geopolitical export-risk exposure. Earnings quality is solid (four consecutive beats), but the valuation is stretched, RSI has elevated from extreme levels, and a broad AI/semi sentiment unwind on June 23 (-9.3% day) underscores downside fragility. No asymmetric mispricing exists at current levels.",
      "verdict": "no_anomaly",
      "confidence": 4,
      "tool_calls": 16,
      "walltime_min": 14,
      "debug_path": "dossiers/2026-06-24-LRCX.scout.debug.json"
    },
    {
      "type": "analyst_decision",
      "ts": "2026-06-17T04:05:44.642Z",
      "skip": true,
      "reason": "Score falls well below the 45-point threshold due to stretched valuation (46x FPE, 58.7x EV/EBITDA) and zero insider buying offset by $50M in sales. Explicit anti-signals (customer concentration, pump signals) trigger the skip gate. While IV is elevated enough for income structures, the lack of mispricing, structural concentration risk, and absence of a concrete asymmetric edge make this unsuitable for publication or paper-tracking.",
      "score": 37,
      "breakdown": {
        "smart_money": 0,
        "options_flow": 4,
        "catalyst": 10,
        "mispricing": 0,
        "quality": 15,
        "technical": 8
      },
      "debug_path": "drafts/2026-06-17-LRCX.analyst.debug.json"
    },
    {
      "type": "scout_dossier",
      "ts": "2026-06-17T04:05:11.255Z",
      "summary": "LRCX is a high-quality semiconductor capital equipment company with exceptional fundamentals — 50% gross margins, 40%+ earnings growth guidance, strong FCF generation. However, the stock has rallied ~159% YTD and sits at a forward P/E of 46x vs sector median ~35x for semis equipment peers; EV/EBITDA of 58.7x is also premium. The Form 4 cluster that triggered this investigation consists entirely of pre-scheduled 10b5-1 SELLING by director Eric Brandt (June 11-12) and SVP Neil Fernandes (June 2), not open-market buying — a critical misread of the trigger signal. There are zero genuine insider purchases in recent filings. The stock is fully valued with limited margin of safety at current prices.",
      "verdict": "range_bound_or_income",
      "confidence": 5,
      "tool_calls": 18,
      "walltime_min": 20,
      "debug_path": "dossiers/2026-06-17-LRCX.scout.debug.json"
    },
    {
      "type": "analyst_decision",
      "ts": "2026-06-10T05:59:09.616Z",
      "skip": true,
      "reason": "Rich valuation (41x Fwd PE, 52x EV/EBITDA) and lack of insider buying leave no margin of safety or mispricing edge; anti-signals for customer concentration and potential dilution further constrain the setup. Upside to consensus targets (~$375) falls short of the 20% return threshold required for publication.",
      "score": 26,
      "breakdown": {
        "smart_money": 0,
        "options_flow": 1,
        "catalyst": 15,
        "mispricing": 0,
        "quality": 5,
        "technical": 5
      },
      "debug_path": "drafts/2026-06-10-LRCX.analyst.debug.json"
    },
    {
      "type": "scout_dossier",
      "ts": "2026-06-10T05:58:42.341Z",
      "summary": "Lam Research is a high-quality semiconductor equipment maker with exceptional fundamentals — 23.8% revenue growth, ~50% gross margins, and consistent EPS beats in every recent quarter (Q3 FY26: +7.9% surprise). However, the stock has run from $88 to $324 (+127%) over the past year and sits only ~7% below its all-time high, with a rich forward P/E of 41x and EV/EBITDA of 52x. No open-market insider purchases were found in the last 90 days — recent Form 4s reflect RSU vestings (A-code) and scheduled Rule 10b5-1 sales, not discretionary buys. The bullish OTM call blocks on June 9 appear speculative rather than informed. WFE demand optimism raised at BofA conference is a real catalyst for July 29 earnings, but the market has already priced much of it in. Valuation does not support an asymmetric long setup; income and range-bound strategies are the appropriate structures.",
      "verdict": "range_bound_or_income",
      "confidence": 5,
      "tool_calls": 20,
      "walltime_min": 25,
      "debug_path": "dossiers/2026-06-10-LRCX.scout.debug.json"
    },
    {
      "type": "analyst_decision",
      "ts": "2026-05-23T00:57:47.273Z",
      "skip": true,
      "reason": "Fully valued mega-cap at all-time highs with zero insider buying, elevated anti-signals (customer concentration >30% and dilution), and no identifiable edge over the 32 sell-side analysts covering the name.",
      "score": 30,
      "breakdown": {
        "smart_money": 0,
        "options_flow": 0,
        "catalyst": 10,
        "mispricing": 0,
        "quality": 15,
        "technical": 5
      },
      "debug_path": "drafts/2026-05-23-LRCX.analyst.debug.json"
    },
    {
      "type": "scout_dossier",
      "ts": "2026-05-23T00:57:22.726Z",
      "summary": "Lam Research is a world-class semiconductor capital equipment maker (deposition, etch, clean) riding a powerful AI-driven WFE expansion cycle. Fundamentals are exceptional — 4 consecutive EPS beats with an average surprise of ~8%, Q3 FY26 revenue $5.84B (+24% YoY), gross margin stable at ~50%, ROIC near 67%. However, the stock is at its all-time high ($305) and trades at a demanding 38.5x forward P/E and 48x EV/EBITDA — premium multiples for a highly cyclical equipment name exposed to geopolitical China risk (34-37% of revenue). The Salzburg AI packaging lab expansion is a real but multi-year product development thesis, not an immediate near-term re-rating catalyst. Zero open-market insider buys in the past 90 days and heavy automated selling through pre-arranged 10b5-1 plans suggest management views current valuations as appropriately set. No asymmetric mispricing exists; this is a fully-valued quality name.",
      "verdict": "range_bound_or_income",
      "confidence": 4,
      "tool_calls": 17,
      "walltime_min": 30,
      "debug_path": "dossiers/2026-05-23-LRCX.scout.debug.json"
    },
    {
      "type": "analyst_decision",
      "ts": "2026-05-14T22:10:16.454Z",
      "skip": true,
      "reason": "The dossier explicitly notes the market has already priced in the AI capex thesis with the stock trading at a significant premium to sector peers (Fwd P/E ~38x, EV/EBITDA ~47x) and lacking insider conviction buys. With a composite score of 40 and no clear mispricing or asymmetric catalyst, this fails the core threshold to publish.",
      "score": 40,
      "breakdown": {
        "smart_money": 0,
        "options_flow": 2,
        "catalyst": 15,
        "mispricing": 0,
        "quality": 15,
        "technical": 8
      },
      "debug_path": "drafts/2026-05-14-LRCX.analyst.debug.json"
    },
    {
      "type": "scout_dossier",
      "ts": "2026-05-14T22:09:07.969Z",
      "summary": "LRCX is a leading semiconductor wafer fabrication equipment maker (etch, deposition, clean) with direct AI/HBM exposure via memory customer capex and advanced packaging. The stock has surged ~252% YTD off the ~$80 low to hit $299 near its 52-week high of $302. Fundamentals are record-caliber — four consecutive quarterly EPS beats (most recent +7.9%), gross margins at ~50%, and FY2026 consensus EPS growth of ~37-40%. However, valuation is rich: forward P/E ~38x, EV/EBITDA ~47x with near-zero SOTP gap to speak of given the stock has already re-rated aggressively off AI enthusiasm. Insider form4 data shows predominantly selling in Q1/Q2 2026 (routine option exercises), not new open-market conviction buys. Options flow confirms strong call-side bias but this partly reflects hedging by a bull consensus crowd rather than contrarian signal. No smoking-gun catalyst beyond continued AI spending, which is already priced in at these levels.",
      "verdict": "range_bound_or_income",
      "confidence": 5,
      "tool_calls": 15,
      "walltime_min": 16,
      "debug_path": "dossiers/2026-05-14-LRCX.scout.debug.json"
    },
    {
      "type": "analyst_decision",
      "ts": "2026-05-07T18:36:10.745Z",
      "skip": true,
      "reason": "Score 36 falls well below the 50-point skip threshold. LRCX trades at a valuation premium (Fwd P/E 36x vs sector 32x) with zero insider buying and active insider selling, leaving no margin of safety for a long thesis. The dossier explicitly recommends income strategies over asymmetric longs, and flagged anti-signal gates for customer concentration and dilution further limit the setup's viability.",
      "score": 36,
      "breakdown": {
        "smart_money": 0,
        "options_flow": 0,
        "catalyst": 20,
        "mispricing": 0,
        "quality": 10,
        "technical": 6
      },
      "debug_path": null
    },
    {
      "type": "scout_dossier",
      "ts": "2026-05-07T18:34:50.245Z",
      "summary": "Lam Research has surged ~300% over the past year on sustained AI-driven semiconductor equipment demand, sitting 4% below its all-time high. The company is fundamentally exceptional—four consecutive positive EPS surprises (3-10%), FY2026 EPS guidance raised to $5.675 (+37% YoY), ROIC of 66.8%, and gross margins expanding. However, at a forward P/E of 36x versus sector median ~30x, the stock leaves no valuation discount for error. Insider Form 4 filings show zero open-market purchases in the past 90 days—all recent activity was RSU vesting, option exercises, or pre-planned Rule 10b5-1 sales (e.g., S=18,170 shares by SVP Fernandes at $255 on May 1). Options flow shows a curious put-heavy volume ratio (3.64 P/C) but net dollar bullish ($192K call bias), with a large out-of-the-money $160 put strike possibly representing structural hedges rather than directional bearish bets. No mispricing exists; the stock is fully priced. The appropriate thesis is income-generation on pullbacks, not an asymmetric long.",
      "verdict": "range_bound_or_income",
      "confidence": 5,
      "tool_calls": 23,
      "walltime_min": 10,
      "debug_path": null
    }
  ],
  "lessons": [],
  "chart_signal": {
    "ticker": "LRCX",
    "call": "BUY",
    "confidence": 5,
    "score": 7,
    "factors": {
      "above_200dma": "+2",
      "above_50dma": "+1",
      "momentum_strong_up": "+2 (216.1%)",
      "rsi_neutral": "0 (58.7)",
      "macd_above_signal": "+1",
      "recent_macd_bullish_cross": "+1 (7d ago)",
      "from_high": "0 (-9.3%)"
    },
    "summary": "BUY (score +7) · 12-1 mom 216.1% · RSI 58.7 · above_both · -9.3% from high",
    "last_close": 371.33,
    "one_month_ago_close": 302.24,
    "twelve_month_ago_close": 95.63,
    "twelve_one_momentum_pct": 216.05,
    "rsi_14": 58.7,
    "ma_stack": "above_both",
    "from_period_high_pct": -9.33,
    "period_high": 409.54,
    "price_targets": {
      "bear": 212.98,
      "fair": 338.41,
      "bull": 480,
      "bear_return_pct": -42.6,
      "fair_return_pct": -8.9,
      "bull_return_pct": 29.3,
      "method": "street_targets ⨯ chart_floors",
      "street": {
        "target_low": 220,
        "target_mean": 340.58066,
        "target_high": 480,
        "analyst_count": 31
      }
    },
    "generated_at": "2026-06-24T07:36:49.773Z"
  }
}